Phase I/II study of cetuximab, capecitabine and oxaliplatin (CAPOX) combined with standard radiotherapy (RTX) as neoadjuvant treatment of advanced rectal cancer (RC)

Arnold, D. and Hipp, M. and Reese, T. and Hohenberger, W. and Liersch, T. and Lordick, F. and Suelberg, H. and Sauer, R. and Roedel, C. (2006) Phase I/II study of cetuximab, capecitabine and oxaliplatin (CAPOX) combined with standard radiotherapy (RTX) as neoadjuvant treatment of advanced rectal cancer (RC). JOURNAL OF CLINICAL ONCOLOGY, 24 (18Supp): 3574. 164S. ISSN 0732-183X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 16 Feb 2021 08:37
Last Modified: 16 Feb 2021 08:37
URI: https://pred.uni-regensburg.de/id/eprint/34433

Actions (login required)

View Item View Item